Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.

Lowin B, Hahne M, Mattmann C, Tschopp J.

Nature. 1994 Aug 25;370(6491):650-2.

PMID:
7520535
2.

Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.

Kataoka T, Shinohara N, Takayama H, Takaku K, Kondo S, Yonehara S, Nagai K.

J Immunol. 1996 May 15;156(10):3678-86.

PMID:
8621902
3.

Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.

Seki N, Brooks AD, Carter CR, Back TC, Parsoneault EM, Smyth MJ, Wiltrout RH, Sayers TJ.

J Immunol. 2002 Apr 1;168(7):3484-92.

4.

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Golstein P.

Science. 1994 Jul 22;265(5171):528-30.

PMID:
7518614
5.

Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes.

Lowin B, Mattman C, Hahne M, Tschopp J.

Int Immunol. 1996 Jan;8(1):57-63.

PMID:
8671589
6.

Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis.

Lee RK, Spielman J, Podack ER.

Int Immunol. 1996 Jul;8(7):991-1000.

PMID:
8757944
7.

MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.

Benihoud K, Bonardelle D, Bobé P, Kiger N.

Eur J Immunol. 1997 Feb;27(2):415-20.

PMID:
9045912
8.

Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis.

Bachmann MF, Ohteki T, Faienza KM, Zakarian A, Kägi D, Speiser DE, Ohashi PS.

J Immunol. 1997 Nov 1;159(9):4165-70.

PMID:
9379009
9.
10.

Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.

Yanai F, Ishii E, Kojima K, Hasegawa A, Azuma T, Hirose S, Suga N, Mitsudome A, Zaitsu M, Ishida Y, Shirakata Y, Sayama K, Hashimoto K, Yasukawa M.

J Immunol. 2003 Feb 15;170(4):2205-13.

11.

Fas- and perforin-independent mechanism of cytotoxic T lymphocyte.

Kajino K, Kajino Y, Greene MI.

Immunol Res. 1998;17(1-2):89-93. Review.

PMID:
9479571
13.
14.

The CTL's kiss of death.

Berke G.

Cell. 1995 Apr 7;81(1):9-12. Review.

15.

Veto activity of activated bone marrow does not require perforin and Fas ligand.

Chrobak P, Gress RE.

Cell Immunol. 2001 Mar 15;208(2):80-7.

PMID:
11333140
17.
18.
19.
20.

Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.

Kafrouni MI, Brown GR, Thiele DL.

J Immunol. 2001 Aug 1;167(3):1566-74.

Supplemental Content

Support Center